Correlation Between DiaMedica Therapeutics and Cellectis
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Cellectis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Cellectis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Cellectis SA, you can compare the effects of market volatilities on DiaMedica Therapeutics and Cellectis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Cellectis. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Cellectis.
Diversification Opportunities for DiaMedica Therapeutics and Cellectis
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between DiaMedica and Cellectis is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Cellectis SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cellectis SA and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Cellectis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cellectis SA has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Cellectis go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Cellectis
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.03 times more return on investment than Cellectis. However, DiaMedica Therapeutics is 1.03 times more volatile than Cellectis SA. It trades about 0.16 of its potential returns per unit of risk. Cellectis SA is currently generating about -0.01 per unit of risk. If you would invest 389.00 in DiaMedica Therapeutics on August 31, 2024 and sell it today you would earn a total of 132.00 from holding DiaMedica Therapeutics or generate 33.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Cellectis SA
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Cellectis SA |
DiaMedica Therapeutics and Cellectis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Cellectis
The main advantage of trading using opposite DiaMedica Therapeutics and Cellectis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Cellectis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellectis will offset losses from the drop in Cellectis' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Cellectis vs. DiaMedica Therapeutics | Cellectis vs. Soleno Therapeutics | Cellectis vs. Genfit | Cellectis vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |